World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 82 15928 14983 670 635 479 31515

Andrea Bezjak publications per year

The chart shows the history of publications by Andrea Bezjak between 1991 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Andrea Bezjak published across 35 years, from 1991 to 2025, averaging 15.2 papers a year. Output peaked at 39 publications in 2009. 33 of the 531 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1991 to 2025. Vertical axis: number of publications, 0 to 39. Peak 39 publications in 2009. 1991: 1 publication 1992: 0 publications 1993: 1 publication 1994: 0 publications 1995: 0 publications 1996: 3 publications 1997: 2 publications 1998: 1 publication 1999: 5 publications 2000: 8 publications 2001: 15 publications 2002: 15 publications 2003: 21 publications 2004: 21 publications 2005: 32 publications 2006: 21 publications 2007: 31 publications 2008: 19 publications 2009: 39 publications 2010: 20 publications 2011: 25 publications 2012: 24 publications 2013: 16 publications 2014: 22 publications 2015: 19 publications 2016: 29 publications 2017: 19 publications 2018: 16 publications 2019: 11 publications 2020: 14 publications 2021: 13 publications 2022: 14 publications 2023: 21 publications 2024: 18 publications 2025: 15 publications
1991 2025

531 publications in total across all disciplines

View publications per year as a table
Andrea Bezjak: publications per year, 1991 to 2025
Year Publications
1991 1
1992 0
1993 1
1994 0
1995 0
1996 3
1997 2
1998 1
1999 5
2000 8
2001 15
2002 15
2003 21
2004 21
2005 32
2006 21
2007 31
2008 19
2009 39
2010 20
2011 25
2012 24
2013 16
2014 22
2015 19
2016 29
2017 19
2018 16
2019 11
2020 14
2021 13
2022 14
2023 21
2024 18
2025 15
Total 531
Download as CSV

Andrea Bezjak publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Andrea Bezjak sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 461–480 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 479 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751 479
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Andrea Bezjak D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Andrea Bezjak sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 82–83 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027 82
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Andrea Bezjak is affiliated with the Princess Margaret Cancer Centre in Canada. Their work primarily focuses on the field of Medicine, with a significant emphasis on several subfields including Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology, Radiation, and Public Health, Environmental and Occupational Health.

Their research topics cover a range of areas related to lung cancer and advanced radiotherapy techniques. These include:

  • Lung Cancer Diagnosis and Treatment
  • Advanced Radiotherapy Techniques
  • Lung Cancer Treatments and Mutations
  • Radiomics and Machine Learning in Medical Imaging
  • Lung Cancer Research Studies
  • Advances in Oncology and Radiotherapy
  • Neuroendocrine Tumor Research Advances

Andrea Bezjak has published extensively, with notable recent papers such as:

  • Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement (2020) in Radiotherapy and Oncology
  • Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement (2020) in International Journal of Radiation Oncology*Biology*Physics
  • Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET) (2024) in International Journal of Radiation Oncology*Biology*Physics
  • Stereotactic Radiation Therapy in Early Non-Small Cell Lung Cancer and Interstitial Lung Disease (2024) in JAMA Oncology
  • Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial (2024) in International Journal of Radiation Oncology*Biology*Physics

The frequent co-authors collaborating with Andrea Bezjak include Meredith Giuliani, Benjamin H. Lok, A. Sun, Andrew Hope, and Srinivas Raman.

Publishing regularly in various academic venues, Andrea Bezjak's work appears most often in the following journals:

  • International Journal of Radiation Oncology*Biology*Physics
  • Radiotherapy and Oncology
  • Journal of Thoracic Oncology
  • Journal of Cancer Education
  • JAMA Oncology

Best Publications

  • Erlotinib in previously treated non-small-cell lung cancer.

    Frances A. Shepherd;José Rodrigues Pereira;Tudor Ciuleanu;Eng Huat Tan

  • Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer

    Robert Timmerman;Rebecca Paulus;James Galvin;Jeffrey Michalski

  • Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases

    Jackson Sai-Yiu Wu;Rebecca Wong;Mary Johnston;Andrea Bezjak

  • Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III Trial

    Christina A. Meyers;Jennifer A. Smith;Andrea Bezjak;Minesh P. Mehta

  • Survival and Neurologic Outcomes in a Randomized Trial of Motexafin Gadolinium and Whole-Brain Radiation Therapy in Brain Metastases

    Minesh P. Mehta;Patrick Rodrigus;C. H J Terhaard;Aroor Rao

  • Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

    Corinne Faivre-Finn;Michael Snee;Linda Ashcroft;Wiebke Appel

  • Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21

    Andrea Bezjak;Dongsheng Tu;Lesley Seymour;Gary Clark

  • Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.

    Andrea Bezjak;Rebecca Paulus;Laurie E. Gaspar;Robert D. Timmerman

  • Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group

    Ralph M. Meyer;Mary K. Gospodarowicz;Joseph M. Connors;Robert G. Pearcey

  • Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: localization, verification, and intrafraction tumor position.

    Thomas G. Purdie;Jean Pierre Bissonnette;Kevin Franks;Andrea Bezjak

  • A randomized placebo-controlled trial of erlotinib in patients with advanced non-small cell lung cancer (NSCLC) following failure of 1st line or 2nd line chemotherapy. A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial

    F. A. Shepherd;J. Pereira;T. E. Ciuleanu;E. H. Tan

  • Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer.

    Frances A. Shepherd;Giuseppe Giaccone;Lesley Seymour;Channa Debruyne

  • Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus.

    Feng-Ming Spring Kong;Timothy Ritter;Douglas J Quint;Suresh Senan

  • Interpreting clinically significant changes in patient-reported outcomes.

    Jolie Ringash;Brian O'Sullivan;Andrea Bezjak;Donald A. Redelmeier

  • Palliative Thoracic Radiotherapy for Lung Cancer: A Systematic Review

    Alysa Fairchild;Kristin Harris;Elizabeth Barnes;Rebecca Wong

  • The Management of Thymoma: A Systematic Review and Practice Guideline

    Conrad B. Falkson;Andrea Bezjak;Gail Darling;Richard Gregg;Richard Gregg

  • Function and Health Status Outcomes in a Randomized Trial Comparing Preoperative and Postoperative Radiotherapy in Extremity Soft Tissue Sarcoma

    Aileen M. Davis;B. O'Sullivan;R. S. Bell;R. Turcotte

  • Solitary plasmacytoma treated with radiotherapy: Impact of tumor size on outcome

    Richard W Tsang;Mary K Gospodarowicz;Melania Pintilie;Andrea Bezjak

  • Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group

    David Osoba;Andrea Bezjak;Michael Brundage;Benny Zee

  • Trimodality Therapy With Induction Chemotherapy Followed by Extrapleural Pneumonectomy and Adjuvant High-Dose Hemithoracic Radiation for Malignant Pleural Mesothelioma

    Marc de Perrot;Ronald Feld;B.C. John Cho;Andrea Bezjak

Frequent Co-Authors

Frances A. Shepherd
Frances A. Shepherd Princess Margaret Cancer Centre
David A. Jaffray
David A. Jaffray The University of Texas MD Anderson Cancer Center
Natasha B. Leighl
Natasha B. Leighl Princess Margaret Cancer Centre
Shaf Keshavjee
Shaf Keshavjee University Health Network
Robert Timmerman
Robert Timmerman The University of Texas Southwestern Medical Center
Laura A. Dawson
Laura A. Dawson Princess Margaret Cancer Centre
Edward Chow
Edward Chow Sunnybrook Health Science Centre
Gerald M. Devins
Gerald M. Devins Princess Margaret Cancer Centre
Marc de Perrot
Marc de Perrot University of Toronto
Geoffrey Liu
Geoffrey Liu Princess Margaret Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to diverse career paths, many of which can be supported by flexible online programs. For registered nurses seeking to advance their careers, rn to np bridge programs offer a streamlined way to progress from ADN to MSN and become a nurse practitioner.

For those passionate about nutrition and its impact on health, the best online nutrition programs provide the foundation needed for roles in dietetics, public health, or private practice.

If you are interested in healthcare leadership and hospital administration, online mha programs accredited by CAHME can help you gain essential management skills with the convenience of distance learning.

Additionally, many nurses are looking for online degree pathways with minimal in-person requirements. The rn to bsn with no clinicals programs can help working nurses earn their BSN while managing other life commitments.

These online options make it easier than ever to take the next step toward a fulfilling healthcare career, no matter your starting point.

Best Scientists Citing Andrea Bezjak

Trending Scientists

Recently Published Articles